相似文献
1
Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis.
Am J Clin Dermatol. 2018 Nov;19(Suppl 1):24-30. doi: 10.1007/s40257-018-0379-0.
2
The sentinel node biopsy has come of age.
Br J Dermatol. 2019 Aug;181(2):423. doi: 10.1111/bjd.17737. Epub 2019 May 6.
3
Sentinel node tumor burden in prediction of prognosis in melanoma patients.
Clin Exp Metastasis. 2020 Apr;37(2):365-376. doi: 10.1007/s10585-020-10028-0. Epub 2020 Feb 19.
4
When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'.
Australas J Dermatol. 2017 Nov;58(4):274-277. doi: 10.1111/ajd.12662. Epub 2017 Jul 17.
5
Time to reconsider the role of sentinel lymph node biopsy in melanoma.
J Am Acad Dermatol. 2019 Apr;80(4):1168-1171. doi: 10.1016/j.jaad.2018.11.026. Epub 2018 Nov 22.
6
[Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Laryngorhinootologie. 2003 Jan;82(1):19-24. doi: 10.1055/s-2003-36906.
7
Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
Clin Dermatol. 2009 Nov-Dec;27(6):594-6. doi: 10.1016/j.clindermatol.2008.09.017.
8
Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
Pol Przegl Chir. 2020 Mar 3;92(3):15-21. doi: 10.5604/01.3001.0013.9041.
9
[Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].
Ann Dermatol Venereol. 2020 Jan;147(1):9-17. doi: 10.1016/j.annder.2019.08.018. Epub 2019 Nov 21.
10
Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Plast Reconstr Surg. 2003 Aug;112(2):486-97. doi: 10.1097/01.PRS.0000070989.23469.1F.
引用本文的文献
1
The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study.
Cancers (Basel). 2023 May 9;15(10):2667. doi: 10.3390/cancers15102667.
2
Rare Tumors of Skin: Malignant Cutaneous Adnexal Tumors and Clinicopathological Features.
Indian J Dermatol. 2023 Jan-Feb;68(1):120. doi: 10.4103/ijd.ijd_838_21.
3
Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer.
Int J Environ Res Public Health. 2023 Feb 16;20(4):3476. doi: 10.3390/ijerph20043476.
4
Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
J Cancer Res Clin Oncol. 2023 Aug;149(9):6315-6328. doi: 10.1007/s00432-023-04577-6. Epub 2023 Feb 6.
5
Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors.
Nat Commun. 2022 Nov 16;13(1):7015. doi: 10.1038/s41467-022-34676-w.
6
Does It Really Pay-Off? Comparison of Lymphadenectomy versus Observational Approach in Skin Melanoma with Positive Sentinel Node Biopsy: Systematic Review and Meta-Analysis.
J Clin Med. 2022 Jul 4;11(13):3880. doi: 10.3390/jcm11133880.
7
Current Trends in Circulating Biomarkers for Melanoma Detection.
Front Med (Lausanne). 2022 Apr 5;9:873728. doi: 10.3389/fmed.2022.873728. eCollection 2022.
8
Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.
Curr Probl Surg. 2022 Jan;59(1):101030. doi: 10.1016/j.cpsurg.2021.101030. Epub 2021 Jul 7.
9
Oxygen Imaging for Non-Invasive Metastasis Detection.
Sensors (Basel). 2021 Dec 29;22(1):237. doi: 10.3390/s22010237.
10
Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma-A Retrospective Single-Institute Study.
Cancers (Basel). 2021 Jun 30;13(13):3302. doi: 10.3390/cancers13133302.
本文引用的文献
1
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
N Engl J Med. 2017 Nov 9;377(19):1824-1835. doi: 10.1056/NEJMoa1709030. Epub 2017 Sep 10.
2
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
N Engl J Med. 2017 Nov 9;377(19):1813-1823. doi: 10.1056/NEJMoa1708539. Epub 2017 Sep 10.
3
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.
4
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
N Engl J Med. 2016 Nov 10;375(19):1845-1855. doi: 10.1056/NEJMoa1611299. Epub 2016 Oct 7.
5
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Lancet Oncol. 2016 Jun;17(6):757-767. doi: 10.1016/S1470-2045(16)00141-8. Epub 2016 May 5.
6
Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
N Engl J Med. 2014 Feb 13;370(7):599-609. doi: 10.1056/NEJMoa1310460.
7
Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
Ann Surg. 2008 Dec;248(6):949-55. doi: 10.1097/SLA.0b013e31818fefe0.
8
The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
J Clin Oncol. 2004 Aug 15;22(16):3345-9. doi: 10.1200/JCO.2004.12.177.
9
Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
Ann Surg. 2003 Oct;238(4):538-49; discussion 549-50. doi: 10.1097/01.sla.0000086543.45557.cb.
10
Prediction of nonsentinel lymph node status in melanoma.
Ann Surg Oncol. 2003 Jan-Feb;10(1):27-31. doi: 10.1245/aso.2003.03.020.
Zotero 插件